Literature DB >> 6615563

Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin.

S S Kerwar, M E Englert, R A McReynolds, M J Landes, J M Lloyd, A L Oronsky, F J Wilson.   

Abstract

Immunization of rats with native bovine type II collagen results in a polyarthritis by day 21 in approximately 40% of the rats. Sera of these rats contained anticollagen IgG, principally IgG2a. Small amounts of IgG2b were also detected, but IgG1 and IgG2c were absent. By enzyme-linked immunosorbent assay, the paw tissue of these polyarthritic rats was shown to contain anticollagen IgG, the principal subclass being IgG2a, with minor amounts of IgG2b. Immunofluorescence examination of the paws from polyarthritic rats demonstrated deposition of both IgG and C3 on the articular surface. Passive transfer of disease was accomplished by injection of affinity-purified anticollagen immunoglobulin into naive recipients; paw swelling and histopathologic changes were detected 24 hours after transfer, and by immunofluorescence techniques IgG and C3 deposits were demonstrable on the articular cartilage. On passive transfer, neutrophils invaded the joint space and became juxtaposed to the surface of the articular cartilage. Passive transfer of the disease with anticollagen immunoglobulin was unsuccessful after rats were decomplemented with cobra venom factor; immunofluorescence demonstrated IgG but not C3 on the articular cartilage of these decomplemented rats. In rats decomplemented with cobra venom factor, neutrophils did not accumulate in the joint and erosion of articular cartilage was not detected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615563     DOI: 10.1002/art.1780260910

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

1.  Studies on type II collagen induced arthritis in mice.

Authors:  W Paska; K J McDonald; M Croft
Journal:  Agents Actions       Date:  1986-06

Review 2.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

3.  Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis.

Authors:  A A Vetto; M Mannik; E Zatarain-Rios; M H Wener
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies.

Authors:  N Loutis; P Bruckner; A Pataki
Journal:  Agents Actions       Date:  1988-12

5.  Extracellular matrix-blood composite injection reduces post-traumatic osteoarthritis after anterior cruciate ligament injury in the rat.

Authors:  Benedikt L Proffen; Jakob T Sieker; Martha M Murray; Matthew R Akelman; Kaitlyn E Chin; Gabriel S Perrone; Tarpit K Patel; Braden C Fleming
Journal:  J Orthop Res       Date:  2015-12-18       Impact factor: 3.494

6.  Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice.

Authors:  S Yoshino; E Sasatomi; M Ohsawa
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

7.  Adjuvant polyarthritis. VIII. Differences in immunopathogenesis between type II collagen arthritis and adjuvant arthritis.

Authors:  Y H Chang; Y Iizuka
Journal:  Agents Actions       Date:  1984-12

8.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Identification of an immunodominant B-cell epitope in bovine type II collagen and the production of antibodies to type II collagen by immunization with a synthetic peptide representing this epitope.

Authors:  K Morgan; S L Turner; I Reynolds; A H Hajeer; A Brass; J Worthington
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

10.  Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.

Authors:  C Nagler-Anderson; L A Bober; M E Robinson; G W Siskind; G J Thorbecke
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.